Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Med Res Rev. 2015 May 25;36(1):92–118. doi: 10.1002/med.21351

Figure 9.

Figure 9

Natural product resorcinol-based inhibitors of Hsp90 (4, 44-46). 47-49 synthetic analogs of 4 to increase in vivo stability. ICa50 represents IC50 values of antiproliferative activity against the MCF-7 breast cancer (4, 44, 47-48) and the KNRK5.2 (49) cell line. ICb50 represents IC50 values of a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.